Goldman Sachs, Pfizer fall premarket; Morgan Stanley, Coinbase rise
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
RBC Capital on Goldman Sachs (GS): 'remain best in class'
January 18, 2023 7:20 AM ESTRBC Capital analyst Gerard Cassidy reiterated a Sector Perform rating and $370.00 price target on Goldman Sachs (NYSE: GS).
The analyst comments "GS is one of the preeminent global investment banks but even with its leading position, market conditions negatively impacted nearly all of its... More
Pfizer (PFE) requires an expense reset for potential upside - Wells Fargo
January 17, 2023 9:57 AM ESTWells Fargo analyst Mohit Bansal downgraded shares of Pfizer (NYSE: PFE) to Equal Weight from Overweight, cutting the firm's price target on the stock to $50 from $54 per share in a note to clients on Tuesday.
Pfizer shares have declined more than 3%... More
